A Community-based HPV screening implementation in Low-Income countries

September 2021 to August 2026
cervical cancer screening
screening practices
self-testing device
Jimma University (Ethiopia)
University Eduardo Mondlane (Mozambique)
Uvri-Iavi Hiv Vaccine Program Limited (Uganda)
Uganda Virus Research Institute (Uganda)
Research fields
Medicine and Health Sciences

Overcoming barriers to human papillomavirus cancer screening

Global implementation of cancer screening can be hindered by differences in cultures and available resources between countries. The EU-funded CHILI project will address this challenge by determining the acceptability, feasibility and cost-effectiveness of the ELEVATE cervical cancer screening tool for women in low-income countries. This portable, battery-powered device comprises a human papillomavirus DNA test and a proteomic biomarkers detection sensor. Social scientists will investigate current screening practices and draw up a tailored strategy embedded in the current health system, while engineers will validate the self-testing device and adapt it for large-scale manufacturing at an affordable cost. Public health specialists and health economists will then evaluate the implementation of the screening tool to determine its suitability and cost-effectiveness.